Page 12 - HFA Dateline 2019-2020 Special Issue
P. 12
Types of Products on the Market
Distribution of
Products on
the Market 2% 12% 30% 56%
Novel Other Plasma- Recombinant
Therapy derived Clotting
Clotting Factor
Factor
Takeda 8
CSL Behring 7
Novo Nordisk 5
Pfizer 4 Products Released by Company Since 2015
Bayer 3 2015 5 Aptevo Therapeutics 1
Grifolsw 3 Bio Products Laboratory 1
Octapharma 3 Octapharma 1
Takeda 2
Ferring Pharmaceuticals 2
Sanofi Genzyme 2 2016 3 Bayer 1
CSL Behring 2
Akorn 1
Aptevo Therapeutics 1 2017 3 Genentech 1
Novo Nordisk 1
Bio Products Laboratory 1
Octapharma 1
Genentech 1
2018 1 Bayer 1
Kedrion BioPharma 1
2019 1 Novo Nordisk 1
2020* 1 HEMA Biologics 1
*More products may be released later this year.
Number of Product Options Per Indication Number
Other 2
Inhibitor 4
vWD 5
Rare 7
IX 10
VIII 21
– 5 10 15 20 25
12 HEMOPHILIA FEDERATION OF AMERICA < www.hemophiliafed.org
